What Do Analysts Think About Vertex Pharmaceuticals (VRTX)?

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best large cap stocks to invest in for the long term. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was initiated with an Outperform rating by Scotiabank on November 12 with a $495 price target. The same day, Evercore ISI reiterated a Buy rating on the stock. However, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) received Hold ratings from Maxim Group analyst Naz Rehman on November 11 and Needham’s Joseph Stringer on November 10. Is V ...